Case | HBS Case Collection | 2004 (Revised from original 1996 version)
by Clayton M. Christensen
Summarizes Eli Lilly's history of innovation in its business, describing how the dimensions along which innovations have been made in the industry have changed. Lilly's innovation strategy has been to pursue ever higher performance products, while others in the industry have pursued more convenient products. At the time of the case, Lilly is contemplating offering services, not just products, to diabetic patients.
Keywords: Change; Product; Service Delivery; Product Development; Innovation and Management; Innovation Strategy; Health Care and Treatment; Pharmaceutical Industry;
Citation:
Christensen, Clayton M. "Eli Lilly and Company: Innovation in Diabetes Care." Harvard Business School Case 696-077, April 2004. (Revised from original February 1996 version.)
View Profile »View Publications »
Book | 2012
How Will You Measure Your Life?
Clayton M. Christensen, James Allworth and Karen Dillon
Book | 2011
The Innovator's DNA: Mastering the Five Skills of Disruptive Innovators
Jeffrey H. Dyer, Hal B. Gregersen and Clayton M. Christensen
Keywords: Competency and Skills; Disruptive Innovation; Competitive Advantage;
Article | Stanford Social Innovation Review | spring 2011
Picking Green Tech's Winners and Losers
Clayton M. Christensen, Shuman Talukdar, Richard Alton and Michael B. Horn
Keywords: Technology;